Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2008 Jun 13;115(3):613–622. doi: 10.1007/s10549-008-0089-z

Table 4.

Combined effects of risk alleles of missense SNPs in each pathway

Pathway No. of risk alleles Cases (%) Controls (%) OR (95% CI) P, trend
BER 3–5 58 (24.5) 102 (21.7) 1.00
6 88 (37.1) 152 (32.3) 1.00 (0.66 – 1.52)
7 64 (27.0) 142 (30.1) 0.80 (0.52 – 1.24)
8–9 27 (11.4) 75 (15.9) 0.63 (0.36 – 1.09)
Per allele 0.88 (0.76 – 1.02) 0.09

NER 5– 9 93 (39.2) 190 (40.3) 1.00
10 57 (24.1) 96 (20.4) 1.21 (0.80 – 1.84)
11 41 (17.3) 102 (21.7) 0.82 (0.53 – 1.28)
12–16 46 (19.4) 83 (17.6) 1.16 (0.74 – 1.80)
Per allele 1.01 (0.92 – 1.11) 0.83

DSB-HR 3–5 74 (31.2) 138 (29.3) 1.00
6 67 (28.3) 145 (30.8) 0.86 (0.57 – 1.30)
7 46 (19.4) 107 (22.7) 0.80 (0.51 – 1.25)
8–12 50 (21.1) 81 (17.2) 1.15 (0.73 – 1.81)
Per allele 0.99 (0.89 – 1.11) 0.84

DSB-NHEJ 2–3 31 (13.1) 96 (20.4) 1.00
4 179 (75.5) 329 (69.9) 1.69 (1.08 – 2.64)
5–6 27 (11.4) 46 (9.8) 1.92 (1.02 – 3.60)
Per allele 1.37 (1.03 – 1.82) 0.03

MMR 2–4 82 (34.6) 188 (39.9) 1.00
5 72 (30.4) 114 (24.2) 1.47 (0.99 – 2.18)
6 46 (19.4) 87 (18.5) 1.23 (0.79 – 1.92)
7–10 37 (15.6) 82 (17.4) 1.03 (0.65 – 1.65)
Per allele 1.07 (0.96 – 1.18) 0.22

DNA Polymerase 3–4 38 (16.0) 70 (14.9) 1.00
5 89 (37.6) 179 (38.0) 0.92 (0.57 – 1.47)
6 95 (40.1) 172 (36.5) 1.01 (0.63 – 1.62)
7–8 15 (6.3) 50 (10.6) 0.55 (0.27 – 1.11)
Per allele 0.94 (0.78 – 1.13) 0.50

0–3 70 (29.5) 130 (27.6) 1.00
Fanconi Anemia groups 4 96 (40.5) 197 (41.8) 0.88 (0.60 – 1.29)
5 59 (24.9) 119 (25.3) 0.91 (0.59 – 1.39)
6 12 (5.1) 25 (5.3) 0.86 (0.40 – 1.82)
Per allele 0.97 (0.83 – 1.14) 0.69